The IOI is developing new drugs for human use and designing alternative antibiotics to use in agriculture and animal feed exclusively to reduce the threat of antimicrobial resistance (AMR) globally. 

IOI’s research is guided by its global surveillance programmes in countries most affected by the threat of AMR including countries in Africa and South Asia. These international collaborative projects enable the IOI to assess the impact of AMR on health and agricultural sectors across the world, and develop the most effective solutions to tackle them.